LIANBIO's ticker is and the CUSIP is 53000N108. A total of 40 filers reported holding LIANBIO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,978 | -34.6% | 32,200 | 0.0% | 0.04% | -36.4% |
| Q2 2023 | $73,416 | +16.3% | 32,200 | 0.0% | 0.07% | +32.0% |
| Q1 2023 | $63,112 | +19.5% | 32,200 | 0.0% | 0.05% | +8.7% |
| Q4 2022 | $52,808 | -17.5% | 32,200 | 0.0% | 0.05% | -13.2% |
| Q3 2022 | $64,000 | -8.6% | 32,200 | 0.0% | 0.05% | -5.4% |
| Q2 2022 | $70,000 | -1.4% | 32,200 | +67.7% | 0.06% | +16.7% |
| Q1 2022 | $71,000 | -1.4% | 19,200 | +64.1% | 0.05% | +6.7% |
| Q4 2021 | $72,000 | – | 11,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,282,084 | $3,742,618 | 5.03% |
| SCHF (GPE), LLC | 937,500 | $1,538 | 2.99% |
| Perceptive Advisors | 57,558,451 | $94,395,859 | 2.65% |
| VR Adviser, LLC | 4,793,047 | $7,860,597 | 1.32% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,303,573 | $5,417,860 | 0.54% |
| Affinity Asset Advisors, LLC | 650,000 | $1,066,000 | 0.42% |
| MYDA Advisors LLC | 135,000 | $221,400 | 0.14% |
| INNOVIS ASSET MANAGEMENT LLC | 176,192 | $288,955 | 0.13% |
| 22NW, LP | 141,223 | $231,606 | 0.12% |
| Logos Global Management LP | 280,000 | $459,200 | 0.05% |